Cargando…
Colchicine-free remission in familial Mediterranean fever: featuring a unique subset of the disease-a case control study
BACKGROUND: To demonstrate and clinically, genetically and demographically characterize familial Mediterranean fever (FMF) patients, maintaining remission despite colchicine abstinence. METHODS: FMF patients were screened for an endurance of prolonged remission (≥ 3 years), despite refraining from c...
Autores principales: | Ben-Zvi, Ilan, Krichely-Vachdi, Tami, Feld, Olga, Lidar, Merav, Kivity, Shaye, Livneh, Avi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3895771/ https://www.ncbi.nlm.nih.gov/pubmed/24401676 http://dx.doi.org/10.1186/1750-1172-9-3 |
Ejemplares similares
-
Determining the origin of different variants associated with familial mediterranean fever by machine-learning
por: Adato, Orit, et al.
Publicado: (2022) -
P01-031 – Anakinra for colchicine resistant FMF
por: Ben-Zvi, I, et al.
Publicado: (2013) -
The Preferential Use of Anakinra in Various Settings of FMF: A Review Applied to an Updated Treatment-Related Perspective of the Disease
por: Giat, Eitan, et al.
Publicado: (2022) -
Screening for Fabry’s disease in a high-risk subpopulation of FMF
por: Maller, Tomer, et al.
Publicado: (2022) -
Safety of the BNT162b2 mRNA COVID-19 vaccine in patients with familial Mediterranean fever
por: Shechtman, Liran, et al.
Publicado: (2022)